102 #RA patients in low dz activity followed for a year - half usual care vs half using smartphone assisted Pt-initiated care. DAS28 slightly increased in both groups without signif difference; app group had less visits (1.7 v 2.8; p<0.001) https://t.co/txttFjjgla https://t.co/TideQ5tVjJ

Upadacitinib in non-radiographic Axial Spondyloarthritis The janus kinase inhibitor, upadacitinib, has been shown to significantly improve the signs and symptoms of nr-AxSpA, extending the efficacy of UPA beyond classic ankylosing spondylitis. https://t.co/BbvOSRxbXU https://t.co/z5QOaFKrxz

In the RECOVERY trial - 8156 hospitalized COVID-19 patients; those on baricitinib had significantly fewer deaths (12% vs 14% PBO) but the size of benefit was somewhat smaller than that suggested by previous trials. (adjusted rate ratio 0·87) https://t.co/EW7xLc9TLC https://t.co/Ahr7bwAQmJ

Risk of incident & recurrent H.Zoster higher after tofacitinib - Korean claims analysis of 11,720 seropos. RA pts Rx w/ bDMARD or tofacitinib (2011-19). 14% got HZ. Compared to other biologics (ABA), Tofa incr HZ (HR 2.5) & recurrence (HR 3.69) https://t.co/lDuqdtkIjR https://t.co/zJ3ArS3gGs

"He who has a strong enough why; can bear almost any how" - Friedrich Nietzsche https://t.co/BOpO9MMijR

Upadacitinib (Rinvoq) Approved by European Commission for use in adults with active Non-Radiographic Axial Spondyloarthritis - 15 mg qd p.o. Approval based on Phase 3 SELECT-AXIS 2 nr-axSpA trial published in Lancet https://t.co/n3Pci5GyoA https://t.co/4aoSOc7xHd

QD Clinic- Still's (or Not): Fever, Joint pain & Itchy Eyes 30 yr. woman with high fevers, itchy eyes and Still's manifestations for 6 weeks. Still's or Not? https://t.co/kbzhCxYp7H https://t.co/FEUzdXxHoW

Not Still’s – Now What? Your patient doesn't meet criteria for Still’s disease (AOSD or sJIA), now what should you do or consider? https://t.co/xPXZVzTXJr https://t.co/7hmhXFh6O3

Approach to ILD in Myositis Syndromes Mehta et al have published a full read review of managing ILD in patients with inflammatory myopathies, a heterogeneous group of syndromes connected by ILD and and increased morbidity and mortality risk. https://t.co/MLBGL2ZqTk https://t.co/cdO2nHAK6h

Rheumatic Causes for Fever of Unknown Origin Fever of unknown origin (FUO) represents a diagnostic challenge to many physicians and while cancer and infectious causes need to be excluded, rheumatic disorders are amongst the most common causes of FUO. https://t.co/2tlibH3SHO https://t.co/QsmkfeGEvb

Physician Assistant Salaries -Amer Academy of Physician Assoc 2022 Report Critical care $122,832 Emer Med $121,480 Surgery $121,400 Cardiology $118,000 Heme/Onc $117,297 Rheumatology $113,000 ID $113,000 GI $113,000 Pulm $112,900 PCP $112,000 https://t.co/14SafbtTGm https://t.co/1yuPI5pAYE

The FDA has extended its indications for ustekinumab (Stelara) for use in pediatric psoriatic arthritis aged 6 years and older. Pediatric PsA makes up 6% of all pediatric inflammatory arthritis pts. https://t.co/vTM4x53n7k https://t.co/aQcuMury2k